These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 793268)

  • 1. Medical treatment in Raynaud's disease.
    Hansteen V
    Acta Chir Scand Suppl; 1976; 465():87-91. PubMed ID: 793268
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on the therapy with a beta-stimulating agent in Raynaud's phenomenon.
    Thune P; Fyrand O
    Acta Chir Scand Suppl; 1976; 465():84-6. PubMed ID: 793267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spasm and Raynaud's phenomenon].
    Fiessinger JN
    Ann Cardiol Angeiol (Paris); 1981; 30(2):91-3. PubMed ID: 7259052
    [No Abstract]   [Full Text] [Related]  

  • 4. [The vasoprostan treatment of patients with Raynaud's syndrome].
    Alekperov RT; Mach ES; Guseva NG
    Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methods for studying vasodilator agents in Raynaud's phenomenon].
    Planchon B; de Faucal P
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():75-7. PubMed ID: 2111690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil for the treatment of Raynaud's phenomenon.
    Heymann WR
    J Am Acad Dermatol; 2006 Sep; 55(3):501-2. PubMed ID: 16908357
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of Raynaud's phenomenon by methyldopa.
    Varadi DP; Lawrence AM
    Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Raynaud's phenomenon].
    Levy Y; Shoenfeld Y
    Harefuah; 1993 Mar; 124(5):288-91. PubMed ID: 8098699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathophysiology and medical treatment of Raynaud's phenomena].
    Adar R
    Harefuah; 1973 Feb; 84(4):227-8. PubMed ID: 4574182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Capilloroscopy of nail folds in Raynaud's syndrome during Hypacom treatment].
    Bendkowski W; Bogdanowski T
    Pol Tyg Lek; 1978 Oct; 33(41):1619-20. PubMed ID: 704471
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's (primary).
    Pope J
    Clin Evid; 2003 Dec; (10):1444-53. PubMed ID: 15555156
    [No Abstract]   [Full Text] [Related]  

  • 14. Plethysmographical and clinical observations on Bricanyl therapy in Raynaud's phenomenon.
    Zabel J; Fyrand O; Thune P
    Acta Derm Venereol; 1974; 54(5):391-5. PubMed ID: 4138501
    [No Abstract]   [Full Text] [Related]  

  • 15. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2005 Jun; (13):1546-54. PubMed ID: 16135302
    [No Abstract]   [Full Text] [Related]  

  • 16. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2004 Dec; (12):1725-34. PubMed ID: 15865744
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL; Littlefield JM; Good RG
    J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al.
    Lichtenstein JR
    Arthritis Rheum; 2003 Jan; 48(1):282-3; author reply 283. PubMed ID: 12528146
    [No Abstract]   [Full Text] [Related]  

  • 20. Raynaud's phenomenon (primary).
    Pope J
    Clin Evid; 2003 Jun; (9):1339-48. PubMed ID: 12967424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.